Fosun Pharma, HOPU Investments, CEL Healthcare Fund, and WuXi PharmaTech to Jointly Acquire U.S. Innovative Biotechnology Company Ambrx
Cellcom Israel Announces First Quarter 2015 Results
Cellcom Israel Ltd. Announces A Loan Agreement
Cellcom Israel Schedules First Quarter 2015 Results Release for May 14, 2015
Use this screen to find overlooked small- and mid-cap international stocks.